UBS Group AG - PETROS PHARMACEUTICALS INC ownership

PETROS PHARMACEUTICALS INC's ticker is PTPI and the CUSIP is 71678J100. A total of 18 filers reported holding PETROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PETROS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$8,000
+14.3%
4,820
+135.2%
0.00%
Q4 2021$7,0000.0%2,049
-43.3%
0.00%
Q3 2021$7,000
+133.3%
3,612
+283.0%
0.00%
Q2 2021$3,000
-76.9%
943
-67.1%
0.00%
Q4 2020$13,0002,8670.00%
Other shareholders
PETROS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CM Management, LLC 100,000$313,0000.23%
Shay Capital LLC 238,764$747,0000.09%
EMFO, LLC 28,000$88,0000.08%
Platform Technology Partners 44,000$138,0000.06%
NorthRock Partners, LLC 219,188$686,0000.06%
ACORN FINANCIAL ADVISORY SERVICES INC /ADV 50,200$157,0000.05%
NEVILLE RODIE & SHAW INC 21,875$68,0000.01%
Virtu Financial LLC 14,364$45,0000.00%
Newbridge Financial Services Group, Inc. 1,200$4,0000.00%
BANK OF AMERICA CORP /DE/ 34$00.00%
View complete list of PETROS PHARMACEUTICALS INC shareholders